Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Board Member operating in the Medical space. If you think a Board Member is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Ben Holmes
Board Member of Kry
Ben is a Partner at Index Ventures, having joined the London office in 2002. Ben focuses on the software and internet sectors and has been actively involved with many of the firm’s consumer and media investments. He currently sits on the boards of Astley Clarke, Grey Area Labs, iZettle, Just-Eat, King.com, Mind Candy, Notonthehighstreet, Rebtel, Secret Escapes, Shapeways, Stardoll and Twoo. He was previously a Director of Panther Express and Playfish (Electronic Arts). Prior to joining Index Ventures, he worked at the NewMedia Spark investment fund, before becoming Vice President at EO plc, a Spark portfolio company in the consumer financial services sector. Previously he spent four years at OC&C Strategy Consultants, advising firms in the retail and IT sectors. He has a Masters degree in Engineering, Economics and Management from Oxford University.
Follow Ben Holmes:
About : Kry helps patients to make active choices about their health in partnership with public and private healthcare professionals.
Hugh Ilyine
Founder & Board Member of ProFactor Pharma
Hugh Ilyine has had an extensive international career in company leadership, operational and marketing roles over the last twenty years. He has undertaken CEO roles in companies active in developing, registering, manufacturing, marketing and distributing IP backed products in Europe, Asia, Australia and New Zealand. His previous experience includes Director, VP and COO at Stem Cell Sciences plc including a successful IPO on AIM in July 2005; establishing the Bio-Science Division of Bonlac Ltd in Melbourne, Australia and a 17 year international career with Rhone-Poulenc’s Agrochemical division including four years as Managing Director of the company’s JV in Indonesia, with supervisory management of Malaysian operations, followed by similar responsibilities for its Australian and New Zealand operations. During his career, he has led and closed a significant number of supply and licence agreements with small and large firms in the US, Europe, Asia and Australia.
Follow Hugh Ilyine:
About DestiNA Genomics: ProFactor Pharma provides commercialise and supply recombinant blood factors for the treatment of haemophilia.
Jean Viry-Babel
CEO, Board Member of xRapid
Follow Jean Viry-Babel:
About xRapid: xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Gary Gibson
Founder & Board Member of Ibex Innovations
Gary is the founder of IBEX Innovations, which he formed in 2010. He developed the fundamental technology behind IBEX and then successfully obtained venture capital backing for the company in 2012. Gary stepped down as CEO in 2013, moving into his current role as Chief Scientific Officer. He also takes management responsibility for the IBEX quality systems. Gary graduated with a PhD from Imperial College, London, in 1999, and then took up a research post at the University of Cambridge. After being offered a fellowship at Cambridge, he moved into research positions in high tech industries, working for a number of blue chip corporations, such as SDL and JDSU, and start-ups such as Intense Photonics. He headed many different research teams but then became fascinated with the interplay between commerce and technology. He shifted his focus to sales and marketing and account management, being promoted to become Deputy Director of Sales and Marketing at Bede X-Ray Metrology, a successful X-ray technology company based in Durham. Gary worked for Kromek for a number of years as a product manager and then Phase Focus, a high-tech start-up in microscopy, as Director of Sales and Marketing.
Follow Gary Gibson:
About Dyman Advanced Materials, Ibex Innovations: IBEX X-ray detector technology adds materials information to silicon based detectors.
Prof Andrew Zisserman FRS
Scientific Advisory Board Member of Optellum
Follow Prof Andrew Zisserman FRS:
About : Optellum develops an imaging biomarker for smart lung cancer detection.
